Creating brighter futures with world-leading spinal cord neuromodulation technology
We are a medical bioelectric solutions company, developing the world’s ﬁrst non-invasive treatments for urinary incontinence due to neurogenic bladder (NB) and the technology to treat cerebral palsy (CP) at the source.
Our Spinal Cord Innovation in Pediatrics (SCiP™) device has been proven through scientific research to treat the root cause of cerebral palsy through spinal cord neuromodulation, leading to remarkable outcomes in children.
Our Spinal Cord Neuromodulator (SCONE™) device is used to treat urinary incontinence in people living with neurogenic bladder due to a spinal cord injury, multiple sclerosis (MS), or stroke, significantly improving their quality of life.
SCiP™ and SCONE™ are investigational devices and are limited by Federal (USA) law to investigational use only. The FDA has not reviewed the safety and efficacy for SCiP™ and SCONE™
Spinal cord neuromodulation
Spinal cord neuromodulation involves the delivery of an electrical charge to the spinal cord. Previously, this could only be done through surgical implantation of electrodes into the spinal cord, but SpineX’s transcutaneous neuromodulation technology is non-invasive.
Electrodes are placed on the skin over specific regions of the spinal cord to deliver electrical stimulation that corrects the underlying neurological deficit, thus restoring function to an end organ. This treatment activates intrinsic control of the spinal networks, enabling recovery of voluntary control.
Built on Science
Our work has been validated through rigorous testing and
Join a clinical trial
If you live with urinary incontinence or other bladder conditions due to a spinal cord injury, stroke, or multiple sclerosis, you may be eligible to join our SCONE™ clinical trial—now actively recruiting at sites around the world.
I can now drive to see my grandkids and not stop every 30 mins to use the public washrooms.
SCONE therapy has allowed me to regain sensation. It's like an internal GPS system.
I am able to sleep for 4 hours for the first time. Before SCONE therapy, I needed to use the restroom 8-10 times at night.
With an estimated market size of more than $15B combined,
our products address a vast unmet clinical need.
Cutting-edge technology, decades in the making.
SpineX is a team of dedicated individuals with deep experience
in the field of spinal cord neuromodulation therapy, working to improve the lives of people living with neurological conditions.